Cycle view
- Bloc
- Organization
- Theory
- Practical
- Others
- Credits
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR0005-1 | Introduction to specialized focus in conception and develoment of medicine - bioanalysis | B2 | Q1 | 10 | |||
| Visites industrielles - [6h Visits of industrial plants] | - | - | [+] | ||||
| Introduction à la biologie clinique - [6h Seminar] | - | - | [+] | ||||
| Médicaments d'origine biosynthétique - [6h Seminar] | - | - | [+] | ||||
| Stratégies de découverte des médicaments - [3h Seminar] | - | - | [+] | ||||
| Chimie structurale des médicaments - [3h Seminar] | - | - | [+] | ||||
| Management pharmaceutique - [3h Seminar] | - | - | [+] | ||||
| Assurance de qualité - [3h Seminar] | - | - | [+] | ||||
| Technologie pharmaceutique industrielle - [3h Seminar] | - | - | [+] | ||||
| Analyses biopharmaceutiques - [6h Seminar] | - | - | [+] | ||||
| Affaires règlementaires - [3h Seminar] | - | - | [+] | ||||
| Etudes cliniques - [3h Seminar] | - | - | [+] | ||||
| Méthodologie de rédaction - [3h Seminar] | - | - | [+] |
Cours au choix de la finalité
- B2
- 20Cr
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| Code | Details | Bloc | Organization | Theory | Practical | Others | Credits |
|---|---|---|---|---|---|---|---|
| PHAR0344-3 | Medicines analysis | B1 | Q1 | 45 | 28 | - | 7 |
| PHAR0343-3 | Pharmaceutical technologies and biopharmacy (part I) | B1 | Q1 | 20 | 60 | - | 4 |
| PHAC0341-2 | Special pharmacology (Part I) | B1 | Q1 | 25 | - | - | 3 |
| TOXI0341-2 | Toxiocological chemistry, Part I | B1 | Q1 | 4 | |||
| Toxiocological chemistry | 25 | - | - | ||||
| Toxicological chemistry, supplement for pharmacy - [12h Seminar] | - | - | [+] | ||||
| BIOC0340-1 | Clinical Chemistry (Part I) - [12h Seminar] | B1 | Q1 | 22 | - | [+] | 4 |
| MBIO0002-1 | Pharmaceutical Microbiology | B1 | Q1 | 16 | - | - | 2 |
| PHAR2018-1 | Officinal pharmaceutical good practices - [6h Seminar] | B1 | Q1 | 10 | - | [+] | 2 |
| ECON0340-1 | Pharmacoeconomy | B1 | Q1 | 10 | - | - | 1 |
| PHAR0003-1
| Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| PHAR0347-3 | Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
| B1 | Q2 | - | 32 | - | 2 |
| PHAC0342-2 | Special pharmacology (Part II)
Corequisite
| B1 | Q2 | 20 | - | - | 2 |
| TOXI0342-2 | Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
| B1 | Q2 | 25 | - | [+] | 4 |
| BIOC0341-1 | Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
| B1 | Q2 | 23 | - | [+] | 4 |
| PHAR0004-1 | Pharamcotherapy and pharmaceutical cares - [10h Seminar] | B1 | Q2 | 30 | - | [+] | 5 |
| SANT0005-1 | Therapeutic approach - [30h Séminaire Interdisciplinaire] | B1 | Q2 | - | - | [+] | 3 |
| LEGI0340-2 | Legislation and pharmaceutical ethics | B1 | Q2 | 30 | - | - | 4 |
| PHAR2219-1 | Integrated work 2 - [30h Learning based on problem-solv]
Corinne Charlier, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Philippe Hubert, Anna Lechanteur, Allison Ledoux, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Vincent Seutin, Eric Ziemons
Corequisite
| B1 | Q2 | - | - | [+] | 3 |
| PHAR2020-1 | Integrated practical activities | B1 | Q2 | 2 | |||
| Integrated practical work | - | 40 | - | ||||
| Industrial visits - [25h Visit]
Corequisite
| - | - | [+] | ||||
| APPR0160-2 | Professional development Seminar - [30h Learning based on problem-solv]
Etienne Cavalier, Corinne Charlier, Alain Chaspierre, Raphaël Denooz, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Philippe Hubert, Anna Lechanteur, Frédéric Lecomte, Anne-Laure Lenoir, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Eric Ziemons
Corequisite
| B2 | Q2 | - | - | [+] | 5 |
Compulsory Training |
|||||||
| PHAR0721-1 | Incorporation of pharmaceutical knowledge
Corinne Charlier, Raphaël Denooz, Brigitte Evrard, Marianne Fillet, Pierre Francotte, Michel Frederich, Julien Hanson, Frédéric Lecomte, Geneviève Philippe, Géraldine Piel, Anne-Catherine Servais, Vincent Seutin
Corequisite
| B2 | Q2 | - | 50 | - | 5 |
| MTFE0351-3 | Officinal Internship and Thesis | B2 | Q2 | 20 | |||
| Record of learning and participation to clinical research project - [100h Personal research] | - | - | [+] | ||||
| Officinal internship and Thesis - [6mois internship]
Prerequisite
Corequisite
| - | - | [+] | ||||
| Notice : Les étudiants doivent accomplir un stage officinal d'une durée légale de six mois (26 semaines), associé à la rédaction d'un dossier d'apprentissage (TFE). Ce stage comprend un stage d'initiation obligatoire de 2 semaines, durant l'été, à l'issue du cycle de bachelier. Pour les étudiants ayant acquis au minimum 45 crédits du bloc 1 du master, le stage officinal peut se poursuivre pendant les vacances d'été précédant l'entrée au bloc 2 du master (maximum 8 semaines). Le solde de semaines (minimum 16 semaines) est presté dans le cadre du bloc 2 du master (2e quadrimestre). |
|||||||